NASDAQ:NEOG - Neogen Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $25.00
  • Forecasted Upside: 12.16 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$22.29
▲ +0.16 (0.72%)

This chart shows the closing price for NEOG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Neogen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NEOG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NEOG

Analyst Price Target is $25.00
▲ +12.16% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Neogen in the last 3 months. The average price target is $25.00, with a high forecast of $25.00 and a low forecast of $25.00. The average price target represents a 12.16% upside from the last price of $22.29.

This chart shows the closing price for NEOG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 1 polled investment analysts is to hold stock in Neogen.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/17/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/18/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/13/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/11/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/11/2022Piper SandlerInitiated CoverageNeutral$25.00N/A
7/23/2020Roth CapitalBoost Price TargetNeutral$16.75 ➝ $18.75Medium
7/21/2020William BlairReiterated RatingMarket PerformLow
7/14/2020StephensReiterated RatingBuy$22.00High
2/10/2020StephensInitiated CoverageEqual Weight ➝ Overweight$22.00High
12/31/2019Roth CapitalReiterated RatingNeutralMedium
7/24/2019Craig HallumBoost Price TargetBuy ➝ In-Line$18.00 ➝ $19.50High
5/23/2019GuggenheimInitiated CoverageNeutral ➝ NeutralHigh
3/19/2019Craig HallumUpgradeHold ➝ Buy$15.69Medium
12/21/2018Craig HallumReiterated RatingHold$15.00High
12/14/2018Roth CapitalReiterated RatingNeutralLow
7/18/2018Craig HallumBoost Price TargetHold$16.25 ➝ $17.50Medium
3/26/2018StephensReiterated RatingEqual Weight ➝ Hold$15.50 ➝ $16.25Medium
1/10/2018StephensReiterated RatingHold$15.50Low
1/4/2018Roth CapitalSet Price TargetHold$20.50 ➝ $15.50Medium
12/7/2017Craig HallumBoost Price TargetHold$11.63 ➝ $15.00Low
12/5/2017Roth CapitalInitiated CoverageNeutral ➝ Neutral$15.38Medium
(Data available from 8/11/2017 forward)

News Sentiment Rating

0.41 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 11 very positive mentions
  • 25 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
1/12/2022
  • 2 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/11/2022
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
3/13/2022
  • 4 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
4/12/2022
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/12/2022
  • 7 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/11/2022
  • 3 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/11/2022
  • 7 very positive mentions
  • 21 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/10/2022

Current Sentiment

  • 7 very positive mentions
  • 21 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Neogen logo
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Read More

Today's Range

Now: $22.29
Low: $21.97
High: $22.52

50 Day Range

MA: $23.26
Low: $21.27
High: $26.84

52 Week Range

Now: $22.29
Low: $21.02
High: $47.80

Volume

76,423 shs

Average Volume

2,586,949 shs

Market Capitalization

$2.40 billion

P/E Ratio

49.53

Dividend Yield

N/A

Beta

0.58

Frequently Asked Questions

What sell-side analysts currently cover shares of Neogen?

The following Wall Street research analysts have issued research reports on Neogen in the last twelve months: Piper Sandler, StockNews.com, and TheStreet.
View the latest analyst ratings for NEOG.

What is the current price target for Neogen?

1 Wall Street analysts have set twelve-month price targets for Neogen in the last year. Their average twelve-month price target is $25.00, suggesting a possible upside of 13.0%. Piper Sandler has the highest price target set, predicting NEOG will reach $25.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $25.00 for Neogen in the next year.
View the latest price targets for NEOG.

What is the current consensus analyst rating for Neogen?

Neogen currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in NEOG, but not buy more shares or sell existing shares.
View the latest ratings for NEOG.

What other companies compete with Neogen?

How do I contact Neogen's investor relations team?

Neogen's physical mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company's listed phone number is (517) 372-9200 and its investor relations email address is [email protected] The official website for Neogen is www.neogen.com. Learn More about contacing Neogen investor relations.